ArticlePlants (Basel, Switzerland)2025
Comparative Analysis of Habitat Expansion Mechanisms for Four Invasive
Article in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Spatiotemporal Dynamics and Climate Change Impacts on Massive Invasive Plants in Henan Province, China.Ecology and evolution · 2026Article
- Projecting Climate-Induced Shifts in the Richness and Spatial Distribution of Invasive Alien Plants Across China Under Alternative Shared Socioeconomic Pathways.Plants (Basel, Switzerland) · 2026Article
- Climate Change Drives Divergent Potential Habitat Dynamics of Invasive and Native Noxious Asteraceae Weeds in Yunnan Grasslands.Plants (Basel, Switzerland) · 2026Article
- National-Scale Conservation Gaps and Priority Areas for Invasive Plant Control in China: An Integrated MaxEnt-InVEST Framework.Plants (Basel, Switzerland) · 2026Article
- The impact of climate change on plant diversity in peatlands in Sichuan province, China.Frontiers in plant science · 2026Article
- Study on potential invasion threat area ofFrontiers in plant science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As China's first systematic assessment of high-risk
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.